AFFiRiS AG has Presented Phase I Data on The Trial for the First Parkinson's Vaccine Candidate

First Clinical Data of Therapeutic Parkinson’s Vaccine is Encouraging

AFFiRiS AG has Presented Phase I Data on a Trial for the First Parkinson’s Vaccine Candidate On the 31st of July 2014, AFFiRiS AG announced as a press conference the results of their phase I clinical trial for a vaccine against Parkinson’s disease.  The vaccine, PD01A, is a therapy that targets the alpha-synuclein protein, a Parkinson’s target. The Michael J.Fox …

Researchers from Duke University have Discovered a Way to Elicit an Immune Response in Individuals Infected With HIV-1, the Most Common Form of the Virus

HIV Vaccine on the Horizon: Researchers Design HIV Immunogens

Researchers from Duke University have Discovered a Way to Elicit an Immune Response in Individuals Infected With HIV-1, the Most Common Form of the Virus The director of the Duke Center for HIV/AIDS Vaccine Immunology and Duke Human Vaccine Institute, Dr.Barton Haynes, recently published his teams findings in the reputable scientific journal ‘Cell.’ In a previous study led by Hayes …

If you’re allergic to dust mites (and chances are you are) help may be on the way

Researchers Create Vaccine for Dust-Mite Allergies

If you’re allergic to dust mites (and chances are you are) help may be on the way Researchers at the University of Iowa have developed a vaccine that can combat dust-mite allergies by changing the body’s immune response. In animal tests, the vaccine lowered lung inflammation by 83 percent, according to the paper published in the AAPS (American Association of …

A new study suggests that HIV patients with a higher level of a particular biomarker may respond more favourably to an experimental immune activating vaccine

New Research Finds a Way to Predict Which HIV Patients Will Respond Better to Future Therapeutic Vaccine

A new study suggests that HIV patients with a higher level of a particular biomarker may respond more favourably to an experimental immune activating vaccine Researchers at St George’s, University of London and Norwegian vaccine company Bionor believe the findings might lead to a customised vaccine for certain patients, which might permit them to come off antiretroviral drugs used to treat …

Vaccine Asia Live: Recombinant Lipoimmunogen-based therapeutic HPV Vaccine

Human Papilloma Virus(HPV) is a DNA virus that can cause skin & genital warts as well as cervical and osopharyngeal cancers. In the US, there is an increasing trend in cervical cancer in women and osopharyngeal cancer in men.  To make things worse, there are no treatments available for HPV infection. Thus, HPV vaccines have become the most common mode …

vaccine

Download presentation: Is a one size fits all influenza vaccine conceivable and practicable?

At the last World Vaccine Congress Asia in 2013, Nikolai Petrovsky, Research Director of Vaxine Pty Ltd gave the following presentation entitled: Is a one size fits all influenza vaccine conceivable and practicable? Download this presentation today! Some of the topics discussed during this presentation include: Previous influenza pandemics The use of animals in influenza vaccine assessment Comparison of the toxicity of …

HIV & AIDS: Facts, figures, and vaccines

This month on Vaccine Nation we’re going to be taking a look at HIV/AIDS vaccines. In the coming weeks we will  look at the current generation of HIV vaccines and the different approaches developers are taking in their attempts to defeat this notorious virus. (The infographic may take a few seconds to load) If you have trouble viewing this inforgraphic …